Alive OS, which is GOQii’s entry, is an omni-channel protocol based on wearables, AI coaches, games and biological age testing from omics science, done largely from a phone. The press release itself makes that clear: this trial was supposed to test safety and feasibility of the intervention, not its efficacy, which will be established in the next trial – a 12-month, assessor-blinded, randomised controlled trial conducted in Mumbai, Delhi NCR, Jaipur and Bengaluru, supervised by an independent Data Safety Monitoring Board. Either way, if Sanjeevini or any other finalist manages to meet the target XPRIZE sets regarding ten to twenty years of health function restoration, the entire concept of health span as a product category will be altered, and it will happen in reverse order from India.